Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | THRA | P10827 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6896113 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL30690962 | 0.91 | ALDH1A1 (0.40) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL4922810 | 0.90 | TSHR (0.42) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL11653544 | 0.90 | TSHR (0.42) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL5965019 | 0.89 | TSHR (0.39) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL5965021 | 0.89 | TSHR (0.39) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL11750627 | 0.87 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL94797 | 0.82 | CYP3A4 (0.70) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL30216004 | 0.82 | TSHR (0.38) | ALDH1A1TSHRCYP3A4ATMTDP1 | |
| SCHEMBL6896110 | 0.82 | TSHR (0.40) | ALDH1A1TSHRCYP3A4ATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220209301-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE FRANCE (FR) | 2022-06-30 | — | — | US | claimed |
| EP-3956288-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE France (FR) | 2022-02-23 | — | — | EP | claimed |
| CN-113795963-A | Carbonate solvents for non-aqueous electrolytes for metal and metal ion batteries | 斯塞法国公司 | 2021-12-14 | — | — | CN | claimed |
| WO-2020212872-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE FRANCE (FR) | 2020-10-22 | — | — | WO | claimed |
| CN-110799514-A | Silole and germacyclopentadiene fused ring photochromic compounds | 光学转变有限公司 | 2020-02-14 | — | — | CN | claimed |
| CN-110730778-A | Photochromic indeno-fused phenanthropyran compounds | 光学转变有限公司 | 2020-01-24 | — | — | CN | claimed |
| WO-2018060018-A1 | USE OF DIALKYL CARBONATES OF BRANCHED ALCOHOLS AS A DISPERSANT | BASF SE (DE) | 2018-04-05 | — | — | WO | claimed |
| EP-3300715-A1 | USE OF DIALKYLCARBONATES OF BRANCHED ALCOHOLS AS DISPERSION AGET | BASF SE (DE) | 2018-04-04 | — | — | EP | claimed |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2025-06-19 | — | — | US | disclosed |
| US-12180217-B2 | Compounds and methods for treatment of viral infections | GILEAD SCIENCES, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| CN-118786128-A | Compounds and methods for treating viral infections | 吉利德科学公司 | 2024-10-15 | — | — | CN | disclosed |
| US-20240246986-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2024-07-25 | — | — | US | disclosed |
| US-20240150359-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2024-05-09 | — | — | US | disclosed |
| CN-101084180-A | Process for producing aromatic carbonate | ASAHI KASEI CHEMICALS CORP (JP) | 2007-12-05 | — | — | CN | disclosed |
| EP-1837328-A1 | PROCESS FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2007-09-26 | — | — | EP | disclosed |
| EP-1829854-A1 | PROCESS FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070055042-A1 | Method for producing an aromatic carbonate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-03-08 | — | — | US | disclosed |
| CN-1839112-A | Method for producing aromatic carbonate | ASAHI CHEMICAL CORP (JP) | 2006-09-27 | — | — | CN | disclosed |
| EP-1640357-A1 | METHOD FOR PRODUCING AROMATIC CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150359-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TSHR 4522/4885CYP3A4 1303/4885 |
| US-12180217-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TSHR 4522/4885CYP3A4 1303/4885 |
| US-20240246986-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TSHR 4522/4885CYP3A4 1303/4885 |
| US-12448383-B2 | Compounds and methods for treatment of viral infections | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TSHR 4522/4885CYP3A4 1303/4885 |
| US-20250197410-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | ALDH1A1 1784/4885TSHR 4522/4885CYP3A4 1303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.